← All Sponsors
SPONSOR

Walden Biosciences

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change DiseasePrimary Immunoglobulin A NephropathyPrimary Membranous Nephropathy
NCT06466135 Phase 2
Recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Diabetic Nephropathies
United States, Australia, India View Trial →